Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $48.18 USD
Change Today -0.06 / -0.12%
Volume 398.6K
KYTH On Other Exchanges
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Keith R. Leonard Jr., M.S., M.B.A.

Co-Founder, Chief Executive Officer, President and Director, Kythera Biopharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 29 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Keith R. Leonard, Jr., M.S., M.B.A. is the President and Chief Executive Officer at Kythera Biopharmaceuticals, Inc. since August 2005. He Co-Founded the firm in 2005. Mr. Leonard serves as the President and Chief Executive Officer at AESTHERx Inc. He served as a Senior Vice president and General Manager at Amgen Europe and was responsible for all commercial operations in 28 countries. From May 1995 to August 1995, Mr. Leonard was responsible to help set up the ...

Read Full Background

Corporate Headquarters*

30930 Russell Ranch Road
Westlake Village, California 91362

United States

Phone: 818-587-4500
Fax: --

Board Members Memberships*

Former Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Co-Founder, Chief Executive Officer, President and Director
Former Director and Member of Compensation Committee
Independent Director


University of California Berkeley
University of California-Los Angeles
University of Maryland
UCLA Anderson School of Management

Other Affiliations*

Annual Compensation*

Total Annual Compensation$448,717

Stock Options*

All Other Compensation$10,200
Exercisable Options201,601
Exercisable Options Value$6,168,120
Unexercisable Options86,294
Unexercisable Options Value$1,583,878
Total Value of Options$9,210,455
Total Number of Options355,753

Total Compensation*

Total Annual Cash Compensation$702,322
Total Short Term Compensation$448,717
Other Long Term Compensation$10,200
Total Calculated Compensation$2,102,874
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KYTH:US $48.18 USD -0.06


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KYTHERA BIOPHARMACEUTICALS I, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at